Augmenting vaccine efficacy against delta variant with ‘Mycobacterium-w’ mediated modulation of NK-ADCC and TLR-MYD88 pathways
View ORCID ProfileSarita Rani Jaiswal, View ORCID ProfileAshraf Saifullah, View ORCID ProfileJaganath Arunachalam, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, Gitali Bhagawati, Hemamalini Aiyer, View ORCID ProfileSubhrajit Biswas, Bakulesh Khamar, View ORCID ProfileSanjay V. Malhotra, View ORCID ProfileSuparno Chakrabarti
doi: https://doi.org/10.1101/2022.11.02.22281822
Sarita Rani Jaiswal
1Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, New Delhi, India
2Department of Blood and Marrow Transplantation, India
5Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India
Ashraf Saifullah
2Department of Blood and Marrow Transplantation, India
Jaganath Arunachalam
1Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, New Delhi, India
Rohit Lakhchaura
2Department of Blood and Marrow Transplantation, India
Dhanir Tailor
6Department of Cell, Development & Cancer Biology and Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Anupama Mehta
2Department of Blood and Marrow Transplantation, India
Gitali Bhagawati
3Department of Pathology and Microbiology, Dharamshila Narayana Super-speciality Hospital, India
Hemamalini Aiyer
3Department of Pathology and Microbiology, Dharamshila Narayana Super-speciality Hospital, India
Subhrajit Biswas
5Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, Uttar Pradesh, India
Bakulesh Khamar
4Research & Development, Cadila Pharmaceuticals Ltd, Ahmedabad, India
Sanjay V. Malhotra
6Department of Cell, Development & Cancer Biology and Center for Experimental Therapeutics, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Suparno Chakrabarti
1Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, New Delhi, India
2Department of Blood and Marrow Transplantation, India
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted November 05, 2022.
Augmenting vaccine efficacy against delta variant with ‘Mycobacterium-w’ mediated modulation of NK-ADCC and TLR-MYD88 pathways
Sarita Rani Jaiswal, Ashraf Saifullah, Jaganath Arunachalam, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, Gitali Bhagawati, Hemamalini Aiyer, Subhrajit Biswas, Bakulesh Khamar, Sanjay V. Malhotra, Suparno Chakrabarti
medRxiv 2022.11.02.22281822; doi: https://doi.org/10.1101/2022.11.02.22281822
Augmenting vaccine efficacy against delta variant with ‘Mycobacterium-w’ mediated modulation of NK-ADCC and TLR-MYD88 pathways
Sarita Rani Jaiswal, Ashraf Saifullah, Jaganath Arunachalam, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, Gitali Bhagawati, Hemamalini Aiyer, Subhrajit Biswas, Bakulesh Khamar, Sanjay V. Malhotra, Suparno Chakrabarti
medRxiv 2022.11.02.22281822; doi: https://doi.org/10.1101/2022.11.02.22281822
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2599)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12134)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4028)
- Geriatric Medicine (379)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (358)
- HIV/AIDS (831)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (563)
- Oncology (1989)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6469)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)